1
TÍTULO: Randomized Comparison of Renal Effects, Efficacy, and Safety With Once-Daily Abacavir/Lamivudine Versus Tenofovir/Emtricitabine, Administered With Efavirenz, in Antiretroviral-Naive, HIV-1-Infected Adults: 48-Week Results From the ASSERT Study
AUTORES: Frank A Post; Graeme J Moyle; Hans Juergen Stellbrink; Pere Domingo; Daniel Podzamczer; Martin Fisher; Anthony G Norden; Matthias Cavassini; Armin Rieger; Marie Aude Khuong Josses; Teresa Branco; Helen C Pearce; Naomi Givens; Cindy Vavro; Michael L Lim;
PUBLICAÇÃO: 2010, FONTE: 12th European AIDS Conference/European-AIDS-Clinical-Society (EACS) in JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 55, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef